Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Greater Cannabis CO Inc (OP: GCAN ) 0.0005 UNCHANGED Streaming Delayed Price Updated: 11:54 AM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,000,001 Open 0.0005 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0005 Today's Range 0.0005 - 0.0005 52wk Range 0.0004 - 0.0015 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Prenatal Cannabis Exposure Not Linked To Elevated Risk Of Autism And Oklahoma Court Rules Pregnant Moms Who Use It Are Not Breaking The Law July 19, 2024 Maternal marijuana use is not related to an increased risk of autism spectrum disorder (ASD) in children who were exposed to cannabis in utero. That's according to newly published data in Autism... Via Benzinga Topics Cannabis Exposures Cannabis Can Marijuana Treat Autism, OCD & Irritable Bowel Syndrome? Ohio Medical Panel Will Investigate February 13, 2023 Ohio researchers want to learn more about the effects of medical marijuana on those with autism spectrum disorder (ASD), obsessive-compulsive disorder (OCD) and irritable bowel syndrome, reported... Via Benzinga Performance YTD -37.50% -37.50% 1 Month -16.67% -16.67% 3 Month -28.57% -28.57% 6 Month -16.67% -16.67% 1 Year -28.57% -28.57% More News Read More Cannabinoids & Autism Spectrum Disorder: This Baltimore Company Is On Track To Start Phase 2 Clinical Trial For New Treatment October 07, 2022 Via Benzinga GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders October 07, 2022 From The Greater Cannabis Company, Inc. Via GlobeNewswire Cannabis Movers & Shakers: Coda Signature, Greater Cannabis Co., BioHarvest Sciences, Compass Pathways December 06, 2021 Via Benzinga Topics Cannabis Exposures Cannabis Greater Cannabis Partners with Shaare Zedek Scientific on Innovative Neuropsychiatric Cannabinoid Therapy August 30, 2021 Via Benzinga Topics Cannabis Exposures Cannabis Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.